Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in locoregionally advanced head & neck squamous cell carcinoma (HNSCC): Updated pathologic response and survival.

Authors: Lara Dunn, Eric Jeffrey Sherman, Jennifer R. Cracchiolo, Ronald A Ghossein, Ian Ganly, Bin Xu, Marc Cohen, Winston Wong, Loren Scott Michel, Anuja Kriplani, Luc Morris, Antoine Desilets, Sean Matthew McBride, Nadeem Riaz, Nancy Y. Lee, Richard J. Wong, David G. Pfister, Alan Loh Ho

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e18117

Source: Full article

Abstract

e18117

Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in locoregionally advanced head &amp; neck squamous cell carcinoma (HNSCC): Updated pathologic response and survival.

Abstract

Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab in locoregionally advanced head & neck squamous cell carcinoma (HNSCC): Updated pathologic response and survival.